IPSC compared with ACRS: revenue, margins and what each company keeps, and the suppliers and customers both name

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

ACRSAclaris Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IPSCCentury Therapeutics, Inc.

ACRSAclaris Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

—Fcdiunlistedsupplier

3 more · IPSC chain ›

Shared 0

No shared counterparties.

Only ACRS 5

LLYEli Lillycustomer

—Biosionunlistedsupplier

—Pediatrix Therapeuticsunlistedcustomer

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Sun Pharmaceutical Industries

unlistedcustomer

1 more · ACRS chain ›

IPSCCentury Therapeutics, Inc.

1.49▲+1.63%

Mkt cap$266.2MRevenue$109MQ1 FY25Revenue$7MFY24

ACRSAclaris Therapeutics, Inc.

3.87▼−2.41%

Regular sessionNov 2 '26

Mkt cap$584.4MRevenue$2MQ2 FY26Revenue$8MFY25

Compare

Regular sessionNov 2 '26

IPSCCentury Therapeutics, Inc.

ACRSAclaris Therapeutics, Inc.

1.49▲+1.63%

Price

3.87▼−2.41%

$266.2M

Mkt cap

$584.4M

Q1 FY25$109M

Revenue

$2MQ2 FY26

FY24$7M

Revenue

$8MFY25

IPSC1.49▲+1.63%vsACRS3.87▼−2.41%Regular sessionNov 2 '26